Yunnan Dianhong Pharmaceutical Group Co., Ltd.

Dianhong Pharmaceutical Group is a prominent Chinese pharmaceutical company specializing in the development and manufacture of over-the-counter (OTC) and Traditional Chinese Medicine (TCM) products. Founded in 1997 and headquartered in Kunming, Yunnan Province, the company built a leading market position in dermatology and gynecology with flagship brands such as Kang Wang. In 2014, Dianhong was acquired by Bayer for approximately $590 million to significantly expand Bayer's consumer health footprint in China. The company's portfolio integrates modern pharmaceutical approaches with standardized herbal medicine, focusing on treatments for fungal infections and women's health. Today, it operates as a key component of Bayer's presence in the Asian healthcare market.